CN101411770A - Medicament for treating blood stasis accumulation type multiple sclerosis symptoms - Google Patents
Medicament for treating blood stasis accumulation type multiple sclerosis symptoms Download PDFInfo
- Publication number
- CN101411770A CN101411770A CNA2008101595409A CN200810159540A CN101411770A CN 101411770 A CN101411770 A CN 101411770A CN A2008101595409 A CNA2008101595409 A CN A2008101595409A CN 200810159540 A CN200810159540 A CN 200810159540A CN 101411770 A CN101411770 A CN 101411770A
- Authority
- CN
- China
- Prior art keywords
- multiple sclerosis
- medicine
- blood stasis
- accumulation type
- type multiple
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a novel medicine for treating blood stasis accumulation type multiple sclerosis, which takes giant knotweed, bupleurumm, radix paeoniae rubra, red sange root, peach kernel, yellow-corktree bark, tree peony bark and safflower as materials. The preparation method comprises: according to different characteristics and mixing ratio of each traditional Chinese medicine, the materials are subjected to water washing and drying, processing, weighting, decocting and concentration, deposition, depositing in alcohol, extraction, drying, crushing and weighing, and are prepared into capsules by a conventional method. The medicine has the advantages of unique formula, obvious curative effect and 100 percent of total effective rate.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine for the treatment of brain section blood stasis accumulation type multiple sclerosis symptoms, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology blood stasis accumulation type multiple sclerosis symptoms is a heart and brain section common clinical.How cause because of stagnation of blood stasis.Usually adopt Western medicine or operative treatment.But western medicine is taken greatly, and the operative treatment patient suffering is big, directly brings spirit and burden economically for patient and family.
It is the medicine of the treatment blood stasis accumulation type multiple sclerosis symptoms of the rule of treatment to promote blood circulation active that summary of the invention the purpose of this invention is to provide a kind of, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's traditional medicine blood stasis accumulation type multiple sclerosis symptoms, with reference to modern pharmacological research, therefrom filter out the demountable natural Chinese medicinal herb of promoting blood circulation, press the Chinese medical theory prescription, make the unobstructed effect of its performance heart and brain.
Medicine of the present invention is the medicament of being made by the following weight proportion raw material
Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g
Above-mentioned each component is made medicament capsule of the present invention according to a conventional method, through washing dry, concoct, weigh, water boiling concentration, precipitation, precipitate with ethanol, extractum, oven dry, pulverize, weigh, encapsulated processing step forms.
Medicine of the present invention is a Chinese medicine preparation, according to the theory of Chinese medical science prescription, selects that medicine is reasonable, dosage form is advanced, active, the treating both the principal and secondary aspects of a disease of promoting blood circulation.Chinese medicinal capsule of the present invention, through clinical observation patient for many years, evident in efficacy, the multiple sclerosis patient that stagnation of blood stasis is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment multiple sclerosis of the medicine of respectively distinguishing the flavor of, and no chemicals is nontoxic to human body, has no side effect, and is safe and reliable.
2, slow fire of the present invention is fried in shallow oil water and is concentrated, and effective ingredient scatters and disappears few, and the curative effect height is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to the blood stasis accumulation type multiple sclerosis symptoms curative effect.
4, clinical drug of the present invention is observed, and can replace the medicine of other treatment blood stasis accumulation type multiple sclerosis symptoms.
For showing the therapeutic effect of medicine of the present invention to blood stasis accumulation type multiple sclerosis symptoms, the present invention is through the clinical observation of 2000 routine blood stasis accumulation type multiple sclerosis symptoms patient systems, and select medical history, the state of an illness, age, sex and multiple sclerosis patients 100 examples suitable to organize as a comparison with traditional therapy, wherein male 1000 examples, woman's 1000 examples, 35～80 years old age, course of disease February～2 year.Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 1 month, checks after half a year, does not have recurrence and is produce effects, and sb.'s illness took a favorable turn is evident as effectively, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Instructions of taking: every 0.5g, one time 23 times on the one, warm water delivery service.
Clinical realization the results are shown in Table 1.
Table 1: take medicine of the present invention and take the observation of curative effect of conventional medicine to the blood stasis accumulation type multiple sclerosis symptoms patient
| Group | Case load | Produce effects (routine number) | Effectively (routine number) | Invalid (routine number) | Total effective rate (%) |
| Test group | 2000 | 1300 | 700 | 0 | 100 |
| Matched group | 100 | 0 | 65 | 35 | 65.0 |
| T | 2.48 | 5.62 | 2.10 | 3.75 | |
| P | <0.05 | <0.05 | <0.05 | <0.05 | <0.05 |
As can be seen from Table 1, medicine of the present invention is obtained 1300 examples that have of significant curative effect to 2000 routine blood stasis accumulation type multiple sclerosis symptoms patients, accounts for 65.0%; That takes a turn for the better has 700 examples, accounts for 35.0%; Total effective rate reaches 100%.
The specific embodiment
Take by weighing raw material by following proportioning:
Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g
Above-mentioned each component is made medicament capsule of the present invention according to a conventional method, through washing dry, concoct, weigh, water boiling concentration, precipitation, precipitate with ethanol, extractum, oven dry, pulverize, weigh, encapsulated processing step forms.
Model case
1, grandson x x, man 62 years old, it is surplus March that blood stasis accumulation type multiple sclerosis symptoms is suffered from clinical examination, took medicament capsule of the present invention 1 month, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
2, Liu x x, man 53 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms year is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
3, Wu x x, man 54 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms year is suffered from clinical examination, took medicament capsule of the present invention 4 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
4, Lee x x, woman 30 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms 3 months is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
5, woods x x, woman 50 years old, it is surplus that blood stasis accumulation type multiple sclerosis symptoms 3 months is suffered from clinical examination, took medicament capsule of the present invention 2 months, and transference cure does not have recurrence in half a year, follow up a case by regular visits to after 1 year, and is normal.
Claims (1)
1, a kind of medicine for the treatment of blood stasis accumulation type multiple sclerosis symptoms dries, concocts, weighs, water boiling concentration, precipitation, precipitate with ethanol, extractum, oven dry, pulverizes, weighs through washing, makes capsule according to a conventional method; It is characterized in that it is made by the following weight proportion raw material: Rhizoma Polygoni Cuspidati 12g Radix Bupleuri 15g Radix Paeoniae Rubra 10g Radix Salviae Miltiorrhizae 10g Semen Persicae 10g Cortex Phellodendri 12g Cortex Moutan 12g Flos Carthami 12g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101595409A CN101411770B (en) | 2008-12-01 | 2008-12-01 | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101595409A CN101411770B (en) | 2008-12-01 | 2008-12-01 | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101411770A true CN101411770A (en) | 2009-04-22 |
| CN101411770B CN101411770B (en) | 2010-12-15 |
Family
ID=40592648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101595409A Expired - Fee Related CN101411770B (en) | 2008-12-01 | 2008-12-01 | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101411770B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933348A (en) * | 2014-04-14 | 2014-07-23 | 韦江南 | Traditional Chinese medicine for treating animal inner damage and preparation method thereof |
| CN105497704A (en) * | 2015-12-23 | 2016-04-20 | 关东升 | Traditional Chinese medicine for treating multiple sclerosis |
| CN108508123A (en) * | 2018-03-07 | 2018-09-07 | 广西医科大学第附属医院 | The anti-chorionitis metabonomic analysis methods of safflower based on LC-MS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050997C (en) * | 1993-01-12 | 2000-04-05 | 王旭文 | Medicinal liquor for curing orthopedic pertinacious disease |
-
2008
- 2008-12-01 CN CN2008101595409A patent/CN101411770B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933348A (en) * | 2014-04-14 | 2014-07-23 | 韦江南 | Traditional Chinese medicine for treating animal inner damage and preparation method thereof |
| CN105497704A (en) * | 2015-12-23 | 2016-04-20 | 关东升 | Traditional Chinese medicine for treating multiple sclerosis |
| CN108508123A (en) * | 2018-03-07 | 2018-09-07 | 广西医科大学第附属医院 | The anti-chorionitis metabonomic analysis methods of safflower based on LC-MS |
| CN108508123B (en) * | 2018-03-07 | 2020-05-12 | 广西医科大学第一附属医院 | Safflower scleroderma-resistant metabonomics analysis method based on liquid chromatography-mass spectrometry |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101411770B (en) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083531B (en) | Drug for treating diabetes | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN102631595B (en) | Medicament for treating II-type diabetes mellitus and preparation method thereof | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN101411770B (en) | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms | |
| CN102512564A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN104547532A (en) | Traditional Chinese medicine preparation for treating migraine and preparation method of traditional Chinese medicine preparation | |
| CN102139049A (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN101411810B (en) | Medicament for treating multiple sclerosis symptoms | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN1246031C (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
| CN101439112B (en) | Medicament for treating leukoderma | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN101411832A (en) | Medicament for treating chronic gastritis | |
| CN100493571C (en) | Medicine for treating heart failure | |
| CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN102988587A (en) | Medicament for treating refractory insomnia and preparation method of medicament | |
| CN103566349A (en) | Medicinal composition for treating hyperglycemia and hyperlipidemia | |
| CN103550668A (en) | Traditional Chinese medicine for treating habitual abortion in gynecology | |
| CN101411831B (en) | Medicament for treating low fever | |
| CN102772763B (en) | Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition | |
| CN100551389C (en) | A kind of medicine for the treatment of early bone tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Lanrong Inventor after: Gu Zongying Inventor after: Guan Bin Inventor after: Wang Xiying Inventor before: Li Lanrong Inventor before: Gu Zongying Inventor before: Guan Bin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI LANRONG GU ZONGYING GUAN BIN TO: LI LANRONG GU ZONGYING GUAN BIN WANG XIYING |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101215 Termination date: 20111201 |